Department of Medicine for Older People, Amsterdam Public Health Research Institute, Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands.
Star-shl Diagnostic Centers, Etten-Leur, the Netherlands.
J Am Med Dir Assoc. 2022 Jun;23(6):968-975.e3. doi: 10.1016/j.jamda.2021.09.010. Epub 2021 Oct 7.
This study evaluated logistics, process data, and barriers/facilitators for the implementation and use of C-reactive protein point-of-care testing (CRP POCT) for suspected lower respiratory tract infections (LRTIs) in nursing home (NH) residents.
This process evaluation was performed alongside a cluster randomized, controlled trial (UPCARE study) to evaluate the effect of CRP POCT on antibiotic prescribing for suspected LRTIs in NH residents.
Eleven NHs in the Netherlands.
Data sources for process data regarding intervention quality included a questionnaire among NH staff, logs, reports, and CRP POCT-analyzer records. Barriers and facilitators for implementation were assessed in focus group interviews with physicians and nurses from 3 NHs.
Correct patient selection for CRP POCT and generally continued CRP POCT use indicated good fidelity. The initial training and training of new employees seemed to fit the need, but some POCT-user group sizes had increased over time, which could have impeded frequent use. Users were generally satisfied with CRP POCT and perceived its use feasible and relevant. Facilitators for implementation were initial commitment and active initiation, followed by continued attention and enthusiasm for building routine practice and trust. Short lines of communication between staff, short distance to the POCT-analyzer, 24/7 coverage of staff, and a clear task division facilitated continued attention and routine practice.
This process evaluation showed sufficient quality of providing CRP POCT in Dutch NHs. We processed findings of intervention quality and implementation knowledge into key recommendations for CRP POCT implementation in this setting. Future research could focus on CRP POCT use in countries with different organization of care in NHs.
本研究评估了 C 反应蛋白床边检测(CRP POCT)用于疑似下呼吸道感染(LRTIs)的护理院(NH)居民的实施和使用的后勤、流程数据以及障碍/促进因素。
本过程评估是与一项集群随机对照试验(UPCARE 研究)同时进行的,以评估 CRP POCT 对 NH 居民疑似 LRTIs 抗生素处方的影响。
荷兰的 11 家 NH。
关于干预质量的流程数据的资料来源包括 NH 工作人员的问卷调查、日志、报告和 CRP POCT 分析仪记录。在 3 家 NH 的焦点小组访谈中评估了实施的障碍和促进因素。
正确选择 CRP POCT 检测的患者,以及普遍持续使用 CRP POCT,表明了良好的忠实度。初始培训和新员工培训似乎符合需求,但随着时间的推移,一些 POCT 用户组的规模有所增加,这可能阻碍了频繁使用。用户普遍对 CRP POCT 感到满意,并认为其使用具有可行性和相关性。实施的促进因素是最初的承诺和积极的启动,其次是持续关注和热情,以建立常规实践和信任。工作人员之间的沟通渠道短、距离 POCT 分析仪近、24/7 覆盖工作人员和明确的任务分工促进了持续关注和常规实践。
本过程评估表明,荷兰 NH 提供 CRP POCT 的质量足够。我们将干预质量和实施知识的研究结果转化为该环境中 CRP POCT 实施的关键建议。未来的研究可以集中在 CRP POCT 在 NH 护理组织不同的国家的使用。